Low-dose antihypertensive therapy with 1.5 mg sustained- release indapamide: Results of randomised double-blind controlled studies
OBJECTIVEIn accordance with international recommendations on the need to decrease doses of antihypertensive drugs, a low-dose (1.5 mg) sustained-release (SR) formulation of indapamide was developed to optimize the drugʼs efficacysafety ratio. The aim of this work was to evaluate the benefit of a low...
Gespeichert in:
Veröffentlicht in: | Journal of hypertension 1998-11, Vol.16 (11), p.1677-1684 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!